MXPA02000330A - Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados. - Google Patents

Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.

Info

Publication number
MXPA02000330A
MXPA02000330A MXPA02000330A MXPA02000330A MXPA02000330A MX PA02000330 A MXPA02000330 A MX PA02000330A MX PA02000330 A MXPA02000330 A MX PA02000330A MX PA02000330 A MXPA02000330 A MX PA02000330A MX PA02000330 A MXPA02000330 A MX PA02000330A
Authority
MX
Mexico
Prior art keywords
methods
pyrrolidines
piperidines
neurotrophic
related compositions
Prior art date
Application number
MXPA02000330A
Other languages
English (en)
Inventor
Mark J Macielag
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA02000330A publication Critical patent/MXPA02000330A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Esta invencion provee compuestos que tienen estructuras generales (I), (II), (III): (ver formulas) esta invencion tambien provee composiciones farmaceuticas que comprenden las mismas y metodos para utilizar estas composiciones para tratar y prevenir trastornos caracterizados por dano neuronal.
MXPA02000330A 1999-07-09 2000-06-14 Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados. MXPA02000330A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14300699P 1999-07-09 1999-07-09
PCT/US2000/016221 WO2001004116A2 (en) 1999-07-09 2000-06-14 Neurotrophic pyrrolidines and piperidines, and related compositions containing them

Publications (1)

Publication Number Publication Date
MXPA02000330A true MXPA02000330A (es) 2004-05-21

Family

ID=22502172

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02000330A MXPA02000330A (es) 1999-07-09 2000-06-14 Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.

Country Status (17)

Country Link
US (1) US6809107B1 (es)
EP (1) EP1202990A2 (es)
JP (1) JP2003504367A (es)
KR (1) KR20020027486A (es)
CN (1) CN1382140A (es)
AR (1) AR034541A1 (es)
AU (1) AU781235B2 (es)
BR (1) BR0012327A (es)
CA (1) CA2379149A1 (es)
CZ (1) CZ200265A3 (es)
HU (1) HUP0202249A3 (es)
IL (2) IL147505A0 (es)
MX (1) MXPA02000330A (es)
PL (1) PL352432A1 (es)
RU (1) RU2241709C2 (es)
TW (1) TW589311B (es)
WO (1) WO2001004116A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835254B1 (fr) * 2002-01-25 2006-04-07 Sod Conseils Rech Applic Derives de thiazoles dans le traitement de maladies neurologiques
DE10240818A1 (de) 2002-08-30 2004-05-13 Grünenthal GmbH Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate
CN1326857C (zh) * 2002-09-30 2007-07-18 神经研究公司 新的1,4－二氮杂双环烷烃衍生物、其制备和应用
US20040266811A1 (en) * 2002-11-08 2004-12-30 Weinstein David E. Methods for inducing regeneration, remyelination, and hypermyelination of nervous tissue
US7189746B2 (en) * 2002-11-08 2007-03-13 Gliamed, Inc. Methods for promoting wound healing
WO2006116808A1 (en) * 2005-04-29 2006-11-09 Metabolic Pharmaceuticals Limited Treating peripheral neuropathies
US20080015236A1 (en) * 2006-02-08 2008-01-17 Weinstein David E Method for promoting myocardial regeneration and uses thereof
US7795216B2 (en) * 2006-03-24 2010-09-14 Glia Med, Inc. Methods for promoting composite tissue regeneration and uses thereof
GB0701426D0 (en) * 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use
TWI534142B (zh) 2011-03-15 2016-05-21 大正製藥股份有限公司 Azole derivatives
CA2922607C (en) * 2013-09-06 2022-08-30 Aurigene Discovery Technologies Limited 1,2,4-oxadiazole derivatives as immunomodulators
JP6596090B2 (ja) * 2014-12-17 2019-10-23 キングス カレッジ ロンドン レチノイン酸受容体ベータ（ＲＡＲβ）アゴニストとしてのビシクロヘテロアリール−ヘテロアリール−安息香酸化合物
EP3383495B1 (en) * 2015-12-04 2021-01-20 The Penn State Research Foundation Chemical reprogramming of human glial cells into neurons with small molecule cocktail
CN114591295B (zh) * 2022-03-04 2023-11-07 贵州大学 含吡啶盐的n-(吲哚酰基)-n’-(取代的)的丙基酰肼类衍生物、其制备方法及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950649A (en) 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
DE3721534A1 (de) * 1986-08-02 1988-02-11 Basf Ag Thiadiazolgruppen enthaltende polymere und deren verwendung in der elektroindustrie
ATE183178T1 (de) 1991-05-09 1999-08-15 Vertex Pharma Neue immunsuppressive verbindungen
US5621101A (en) 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5461146A (en) 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5756494A (en) 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
NZ314207A (en) 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
ATE299145T1 (de) 1994-08-18 2005-07-15 Ariad Gene Therapeutics Inc Neues multimerisierendes reagenz
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
AU731826B2 (en) 1996-02-28 2001-04-05 Ariad Pharmaceuticals, Inc. Synthetic Multimerizing Agents
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
PA8442401A1 (es) 1996-12-09 2000-05-24 Guilford Pharm Inc Inhibidores polipropilos de ciclofilina
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5935989A (en) * 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) * 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
AU742040C (en) * 1997-09-24 2003-10-02 Amgen, Inc. Method for preventing and treating hearing loss using sensorineurotrophic compounds
GB9804426D0 (en) 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
IL140039A0 (en) * 1998-06-03 2002-02-10 Guilford Pharm Inc Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
EP1084107B1 (en) * 1998-06-03 2007-04-11 GPI NIL Holdings, Inc. Aza-heterocyclic compounds used to treat neurological disorders and hair loss
PL345110A1 (en) * 1998-06-03 2001-12-03 Gpi Nil Holdings Aza-heterocyclic compounds used to treat neurological disorders and hair loss
US6284779B1 (en) 1999-02-03 2001-09-04 Schering Aktiiengesellschaft Heteroaromatic compounds

Also Published As

Publication number Publication date
WO2001004116A2 (en) 2001-01-18
CZ200265A3 (cs) 2002-07-17
IL147505A0 (en) 2002-08-14
US6809107B1 (en) 2004-10-26
PL352432A1 (en) 2003-08-25
JP2003504367A (ja) 2003-02-04
EP1202990A2 (en) 2002-05-08
CN1382140A (zh) 2002-11-27
WO2001004116A3 (en) 2001-08-23
AU5485500A (en) 2001-01-30
HUP0202249A3 (en) 2003-01-28
TW589311B (en) 2004-06-01
CA2379149A1 (en) 2001-01-18
HUP0202249A2 (hu) 2002-12-28
KR20020027486A (ko) 2002-04-13
RU2241709C2 (ru) 2004-12-10
BR0012327A (pt) 2002-07-02
AU781235B2 (en) 2005-05-12
AR034541A1 (es) 2004-03-03
IL147505A (en) 2006-07-05

Similar Documents

Publication Publication Date Title
AU3652102A (en) Compounds and their uses
AP9901478A0 (en) Compounds for the treatment of ischemia.
AP2001002187A0 (en) Piperidines as CCR5 modulators.
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
WO2002072031A3 (en) Substituted tetracycline compounds as synergistic antifungal agents
YU38801A (sh) Azabicikloalkani kao modulatori ccr5
MX9702865A (es) Agentes estrogenicos.
BG108660A (en) Pyrrolidinone derivatives
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
MXPA02000330A (es) Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.
ES2158778A1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
AU6469401A (en) Pharmaceutically active compounds and methods of use
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
ES2159260A1 (es) Nueva composicion de metanosulfonato de paroxetina
WO2001041755A3 (en) Topical compositions comprising thalidomide for the treatment of inflammatory diseases
WO2001004090A3 (en) Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.